top of page
Cancer Blog
- Dr. Robert Nagourney -
Search

Revolutionizing Breast Cancer Screening: The Promise of Metabolomics
metabolomics are poised to revolutionize breast cancer screening by enhancing diagnostic accuracy and reducing patient discomfort.
Dr. Robert A. Nagourney, MD
Jan 202 min read


Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?
Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.
Dr. Robert A. Nagourney, MD
Nov 19, 20243 min read

Metastatic Breast Cancer Claims Another Life
I received a video from an episode of Americas Got Talent, the popular TV program that features up-and-coming performers.
Dr. Robert A. Nagourney, MD
Sep 26, 20242 min read


What Have Medical Oncologists Lost? Empathy!
Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.
Dr. Robert A. Nagourney, MD
Jan 31, 20243 min read

For Advanced Cancer Patients: Whose Life is It Anyway?
Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.
Dr. Robert A. Nagourney, MD
Jan 23, 20243 min read

A Triple Negative Breast Cancer Patient's Journey: Going the Extra Mile
This patient had recurrent breast cancer that upon biopsy proved to be triple negative.
Dr. Robert A. Nagourney, MD
Oct 10, 20233 min read

Pancreatic Cancer Surgery: Know What You Have Consented To!
However, a new dilemma has arisen; the failure of surgeons to comply with Pancreatic Cancer patient’s wishes to have tissue submitted.
Dr. Robert A. Nagourney, MD
Aug 30, 20232 min read

Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good
There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.
Dr. Robert A. Nagourney, MD
Jul 24, 20232 min read

Challenging Paradigms: The Management of Rectal Cancer
One noteworthy case was a 78-year-old patient successfully treated without surgery.
Dr. Robert A. Nagourney, MD
Jun 26, 20233 min read


IN HER2 (+) BREAST CANCER, THE MOST WIDELY USED TREATMENT MAY NOT BE THE RIGHT ONE FOR YOU
Despite advances in breast cancer management, we must all recognize that every patient is unique and their treatments should be too.
Dr. Robert A. Nagourney, MD
Aug 30, 20222 min read


Stage 4 Triple-Negative Breast Cancer: The Right Treatment May Be At Hand.
A famous medical center recommended a treatment widely used for breast cancer, but not necessarily the best one for Stage 4 Triple-Negative.
Dr. Robert A. Nagourney, MD
Aug 11, 20223 min read


IN LUNG AND BREAST CANCER COMBINED CHEMO-IMMUNOTHERAPY LOOKS BEST, BUT WHICH DRUGS?
With the explosion of immunotherapy in oncology, the checkpoint inhibitors (Pembrolizumab, Nivolumab, Ipililumab, etc.) are being used in...
Dr. Robert A. Nagourney, MD
Feb 15, 20214 min read

Stage IV HER2 Positive Breast Cancer: The Art of Oncology
Among Michelangelo's most famous sculptures are the 'Prisoners” that depict human forms awakening from their marble entrapment. The...
Dr. Robert A. Nagourney, MD
Sep 7, 20205 min read

Interstate Oncology: Breast Cancer Patient On the Run
Of the one million new breast cancer patients diagnosed each year worldwide, approximately 170,000 of these cases are triple negative....
Dr. Robert A. Nagourney, MD
Aug 2, 20193 min read


Woman with Both Breast and Pancreatic Cancer: Finding an Achilles Heel
With the rapid rise of cancer, medical oncologists sometimes find themselves treating family members, friends or neighbors. In 2008, the...
Dr. Robert A. Nagourney, MD
Jan 12, 20195 min read


Serendipity Saves a Life for a Patient with Advanced Breast Cancer
In early September of 2018, I consulted with a 51-year-old patient with heavily pre-treated, extremely advanced metastatic breast cancer....
Dr. Robert A. Nagourney, MD
Nov 20, 20185 min read

In Advanced Breast Cancer, Sometimes the Patient Knows Best
She had been diagnosed in December 2012 with estrogen receptor positive breast cancer and received appropriate and aggressive therapy.
Dr. Robert A. Nagourney, MD
Feb 9, 20184 min read
Complete Response in Triple Negative Breast Cancer Treatment
Triple negative breast cancer (TNBC) represents a distinct form of breast cancer that does not express estrogen receptors (ER),...
Dr. Robert A. Nagourney, MD
Jun 14, 20163 min read
For Advanced Breast Cancer, Taxol is Still Best of its Class
An important trial result was reported for patients with advanced breast cancer. A total of 783 patients with stage IIIC/IV disease,...
Dr. Robert A. Nagourney, MD
Jul 15, 20152 min read
Is There a Role for PI3k Inhibitors in Breast Cancer? Maybe.
Over the past decades oncologists have learned that cancer is driven by circuits known as signal transduction pathways. The first...
Dr. Robert A. Nagourney, MD
Mar 20, 20153 min read
bottom of page